Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T38824 |
GT-1
LCB10-0200,GT-1 |
Others | Others |
GT-1 (LCB10-0200) is a siderophore-linked cephalosporin compound that effectively combats clinical isolates of various bacterial species, including P. aeruginosa, Klebsiella oxytoca, Proteus spp., Serratia marcescens, and Enterobacter aerogenes. | |||
T23787 |
BGT1-IN-9
BGT1 IN 9,BGT1 inhibitor 9,BGT1IN9,BGT1-inhibitor-9 |
Others | Others |
BGT1-IN-9 is an M1 muscarinic agonist. | |||
T68939 |
GT11
|
Others | Others |
GT-11 is an inhibitor of dihydroceramides (DHCer) desaturase activity. | |||
T36862 |
Ganglioside GT1b Mixture (sodium salt)
Ganglioside GT1b Mixture (sodium salt),Ganglioside G1 Mixture |
Others | Others |
Ganglioside GT1b is a trisialoganglioside that is characterized by having two sialic residues linked to the inner galactose unit. It binds to the neurotoxins botulinum toxin serotype A (BTxA), BTxA heavy chain, and tetanus toxin with IC50 values of 11, 0.74, and 7.2 μM, respectively.[1] Ganglioside GT1b-containing liposomes bind to the major coat protein VP1 from Merkel cell polyomavirus (MCPyV), which has been identified in Merkel cell carcinomas, identifying ganglioside GT1b as a putative MCP... | |||
T35043 |
Vedroprevir
GS9451,GS 9451,GS-9451 |
Others | Others |
Vedroprevir, also known as GS9451, is a selective hepatitis C virus (HCV) NS3 protease inhibitor in the development of the treatment of genotype 1 (GT1) HCV infection. |